No Detail Found!

Vestibular rehabilitation with intratympanic drug therapy in meniere's disease

Author(s)
Zeeshan Ayub Combined Military Hospital Quetta/National University of Medical Sciences (NUMS), Pakistan
Ahmed Hasan Ashfaq Combined Military Hospital Quetta/National University of Medical Sciences (NUMS), Pakistan
Amir Ali Khan Combined Military Hospital Quetta/National University of Medical Sciences (NUMS), Pakistan
Kamran Ashfaq Ahmed Butt Combined Military Hospital Quetta/National University of Medical Sciences (NUMS), Pakistan
Abstract
Objective: To evaluate vertigo control and auditory rescue in patients with Meniere's disease treated with intratympanic Gentamicin and Dexamethasone. Study Design: Randomized Control Trial (Clinical Trials. gov Identifier: NCT05355610). Place and Duration of Study: ENT Departments CMH Quetta and Benazir Bhutto Hospital Rawalpindi Pakistan from Apr 2020 to Mar 2022. Methodology: Ninety-three cases of unilateral Meniere's disease meeting the inclusion criteria were treated with intratympanic Gentamicin and Dexamethasone. Pre and post-treatment vertigo was assessed on Vestibular Deficit Index. Speech discrimination scores for auditory impact were also recorded pre and post-treatment. Results: In the Ninety-three treated cases, there was a statistically significant improvement in the Vestibular Deficit Index (with a p-value of 0.001). Although all patients had a reduced speech discrimination score, it was not statistically significant (p value=0.08). Conclusion: Control of vestibular symptoms can be achieved with intratympanic Gentamicin, and at the same time, the auditory system can be rescued with Dexamethasone.
Publication Details
Page(s) 1444-1447
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 72, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
Dexamethasone, Gentamicin, Intratympanic.
0

Citations

0

Downloads

92

Views